Cyclo-oxygenase (COX) inhibitors are associated with increased cardiovascular risk, and are, therefore, contraindicated in patients with a previous myocardial infarction (MI). Although NSAIDs might induce a similar cardiovascular risk, some guidelines suggest that they can be administered safely for a short period of time. But is this really true?
机构:
Department of Cardiology and Angiology, Hannover Medical School, 30625 HannoverDepartment of Cardiology and Angiology, Hannover Medical School, 30625 Hannover
Meyer G.P.
Wollert K.C.
论文数: 0引用数: 0
h-index: 0
机构:
Department of Cardiology and Angiology, Hannover Medical School, 30625 HannoverDepartment of Cardiology and Angiology, Hannover Medical School, 30625 Hannover
Wollert K.C.
Drexler H.
论文数: 0引用数: 0
h-index: 0
机构:
Department of Cardiology and Angiology, Hannover Medical School, 30625 HannoverDepartment of Cardiology and Angiology, Hannover Medical School, 30625 Hannover